Navigating the Complexities of Lung Transplantation in Connective Tissue Disease–Associated ILD
Register Now
Connective tissue disorder–associated interstitial lung disease (CTD-ILD) is an increasingly common indication for lung transplantation, yet it presents unique and multifaceted challenges across the transplant continuum. CTD-ILD patients often face significant multisystem involvement, including esophageal dysmotility, gastroesophageal reflux, pulmonary hypertension, renal impairment, and musculoskeletal limitations. Both achieving control of extrapulmonary autoimmune manifestations before transplant and maintaining it afterwards can be challenging. This webinar will explore the evolving landscape of CTD-ILD transplantation, highlighting advances in patient selection, surgical considerations, and post-transplant management.
16 January, 2026 1:00 p.m. to 2:00 p.m. EST
Connective tissue disorder–associated interstitial lung disease (CTD-ILD) is an increasingly common indication for lung transplantation, yet it presents unique and multifaceted challenges across the transplant continuum. CTD-ILD patients often face significant multisystem involvement, including esophageal dysmotility, gastroesophageal reflux, pulmonary hypertension, renal impairment, and musculoskeletal limitations. Both achieving control of extrapulmonary autoimmune manifestations before transplant and maintaining it afterwards can be challenging. This webinar will explore the evolving landscape of CTD-ILD transplantation, highlighting advances in patient selection, surgical considerations, and post-transplant management.
Moderators
Aida Venado, MD
Lorenzo Zaffiri, MD, PhD
Presentations
Managing the Extrapulmonary Manifestations of Connective Tissue Disease in Patients Undergoing Lung Transplant for CTD-ILD
Presented by Andrew Gross, MD
Comprehensive Management of Lung Transplantation for CTD-Associated ILD
Presented by Jerome Le Pavec, MD, PhD
Q&A
Led by Moderators
